Abstract
Detection of V-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutation is important for clinical diagnosis, treatment decision-making, effect judgement and prognosis evaluation in papillary thyroid carcinoma (PTC). Research has shown that peripheral blood BRAF V600E is closely related to the histological level of BRAF V600E. Detection of peripheral blood BRAF V600E mutation will be less traumatic, more convenient and dynamic, indicating that it will be the future development trend of PTC research. Key words: V-raf murine sarcoma viral oncogene homolog B1 oncogene; Circulating tumor DNA; Papillary thyroid carcinoma; Progress
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
